CJC 1295 with DAC CD10 10mg*10vials

CJC 1295 (containing DAC CD10), 10mg x 10 vials, is a high-purity, long-acting growth hormone secretion peptide, belonging to the high-end growth hormone peptide research series. This product utilizes DAC (drug affinity complex) modification technology. Compared to the traditional unmodified CJC 1295, the upgraded 10mg high-concentration formulation significantly extends the half-life while maintaining biological activity. Produced through multi-stage pharmaceutical-grade purification and vacuum freeze-drying processes, the freeze-dried powder exhibits ultra-high purity, excellent water solubility, and strict batch-to-batch consistency. During storage and reconstitution, it effectively maintains the stability of its molecular structure, meeting the high-precision experimental standards of professional laboratories, preclinical pharmacology studies, and long-term endocrine mechanism research.

Product Functions and Research Value

CJC 1295, a core long-acting growth hormone-releasing hormone receptor (GHSR) agonist containing DAC CD10, specifically targets and activates the growth hormone secretagogue receptor, stably stimulating the pulsatile secretion of endogenous growth hormone and upregulating the level of the insulin-like growth factor-1 (IGF-1) axis in vivo. In laboratory studies, this peptide has been widely used to explore the biological mechanisms of endocrine regulation, lean muscle anabolism, basal metabolic enhancement, adipose tissue breakdown, and anti-aging. Thanks to its unique DAC sustained-release structure, it provides continuous and stable physiological activation without frequent dosing, effectively avoiding the peak-trough fluctuations of ordinary short-acting growth hormone secretagogues. The 10mg high-dose specification supports high-intensity endocrine intervention, long-term physiological remodeling, and the synergistic effects of peptide compounds, providing highly linear, reproducible, and reliable research data for advanced endocrine and metabolic studies.

Core Product Advantages

1. Long-acting DAC sustained-release technology: Professional DAC structural modification significantly prolongs the molecular half-life, achieving long-acting and stable GH/IGF-1 axis activation and endocrine regulation. 2. 10mg High-Purity Upgrade Specification: The high-concentration single-vial dose meets the needs of high-intensity pharmacological interventions and long-term experimental modeling, offering superior experimental range and stability compared to the low-dose standard specification.

3. Powerful Endocrine Regulation Performance: Effectively activates the GHSR pathway, promotes orderly growth hormone secretion, enhances anabolism, accelerates lipid metabolism, and assists in systemic component optimization studies.

4. Excellent Stability and Solubility: High-quality lyophilized powder dissolves rapidly and completely in antibacterial water, forming a uniform solution concentration, ensuring the purity of experimental variables and avoiding interference from impurities.

5. High-Performance Liquid Chromatography (HPLC) Detection and Complete Certification: Meets stringent pharmaceutical purification standards, exhibits excellent batch-to-batch activity stability, and comes with a complete Certificate of Authorization (COA), suitable for academic laboratory research, preclinical drug development, and global bulk wholesale procurement.

CJC 1295 (containing DAC CD10, 10mg*10 vials) is a long-acting, high-purity growth hormone-releasing hormone receptor (GHSR) agonist research peptide, specifically designed for research on the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis and the endocrine system. This product features a DAC sustained-release structure, stable metabolic activation, and enhanced anabolic performance, supporting laboratory studies on body composition optimization, lipid metabolism, and anti-aging mechanisms. HPLC-validated and accompanied by a complete Certificate of Authorization (COA), it is available for global wholesale.